Saitama Medical Center

Kawagoeshi, Saitama 350-8550

1 studies enrolling now · 5 studies all time

What they study most

Bronchopulmonary Dysplasia, CLL, Chronic Lung Disease of Prematurity, Chronic Lymphocytic Leukemia, Intraventricular Hemorrhage, Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Retinopathy of Prematurity (ROP), Rheumatoid Arthritis

Studies at this site

• A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors — Recruiting now
• A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants — Running, not enrolling
• Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. — Completed
• A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed